Understanding the Complexities of Cirrhosis

被引:40
作者
Muir, Andrew J. [1 ]
机构
[1] Duke Univ, Sch Med, Div Gastroenterol, Durham, NC 27710 USA
关键词
chronic liver disease; cirrhosis; fibrosis; primary care; portal hypertension; CHRONIC HEPATITIS-C; INTERFERON-FREE STRATEGIES; VENOUS-PRESSURE GRADIENT; FATTY LIVER-DISEASE; TRANSIENT ELASTOGRAPHY; NATURAL-HISTORY; PRIMARY-CARE; GASTROESOPHAGEAL VARICES; HEPATOCELLULAR-CARCINOMA; NONINVASIVE DIAGNOSIS;
D O I
10.1016/j.clinthera.2015.05.507
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: Cirrhosis and its related complications remain a prominent global health concern despite advances in understanding and treating the disorder. Early diagnosis and intervention strategies may reduce the impact of cirrhosis; however, it can be difficult for initial point-of-care health care providers to identify and refer patients with cirrhosis due to lack of knowledge and resources. This review examines current diagnostic strategies for cirrhosis and cirrhosis-related complications and the potential benefits of multidisciplinary care for patients with the disorder. Methods: A Pub Med search of the medical literature was conducted to identify current diagnostic methods and standards and ascertain the impact of multidisciplinary care on patients with cirrhosis. Findings: Screening of patients at risk for cirrhosis has been recommended by several professional and governmental organizations. Unfortunately, identification of early-stage cirrhosis remains challenging despite development of novel calculations for risk (eg, aspartate transaminase-to-platelet count ratio) that use values from common, noninvasive laboratory tests to determine the extent of liver disease. Abnormal liver function test results and alterations in serum liver enzyme markers (eg, alanine and aspartate transaminases) may suggest cirrhosis in patients with chronic liver disease; however, they are not definitive. Liver biopsy is the gold standard for diagnosis and staging of cirrhosis, but its cost, invasiveness, and risk of complications have prompted the development of noninvasive tests (eg, elastography). Primary care physicians should be aware of the signs and symptoms of cirrhosis-related complications, particularly portal hypertension, and refer patients to specialists for further evaluation when warranted. Implications: Patients at risk for cirrhosis should be screened and the underlying etiologic factor(s) of the liver disease treated or appropriately managed when possible. Primary care physicians should be aware of the signs and symptoms of cirrhosis and its related complications and adopt a low threshold for referral to a specialist when the condition is suspected. An integrated, multidisciplinary approach to care between specialists and primary care physicians may improve early detection of cirrhosis and its related complications and strengthen management strategies. (C) 2015 The Authors. Published by Elsevier HS Journals, Inc.
引用
收藏
页码:1822 / 1836
页数:15
相关论文
共 112 条
[21]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[22]   Histopathology of nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Tiniakos, Dina G. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (42) :5286-5296
[23]   Liver Fibrosis: Noninvasive Assessment with Acoustic Radiation Force Impulse Elastography-Comparison with FibroScan M and XL Probes and FibroTest in Patients with Chronic Liver Disease [J].
Cassinotto, Christophe ;
Lapuyade, Bruno ;
Ait-Ali, Ania ;
Vergniol, Julien ;
Gaye, Delphine ;
Foucher, Juliette ;
Bailacq-Auder, Claire ;
Chermak, Faiza ;
Le Bail, Brigitte ;
de Ledinghen, Victor .
RADIOLOGY, 2013, 269 (01) :283-292
[24]  
Centers for Medicare & Medicaid Services, 2014, DEC MEM SCREEN HEP C
[25]   The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (06) :811-826
[26]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231
[27]   Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients [J].
D'Amico, G. ;
Pasta, L. ;
Morabito, A. ;
D'Amico, M. ;
Caltagirone, M. ;
Malizia, G. ;
Tine, F. ;
Giannuoli, G. ;
Traina, M. ;
Vizzini, G. ;
Politi, F. ;
Luca, A. ;
Virdone, R. ;
Licata, A. ;
Pagliaro, L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) :1180-1193
[28]  
Davies SC., 2012, Annual report of the chief medical officer: on the state of the public's health, V1
[29]   Evolving consensus in portal hypertension - Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension [J].
de Franchis, R .
JOURNAL OF HEPATOLOGY, 2005, 43 (01) :167-176
[30]   Noninvasive diagnosis of cirrhosis: A review of different imaging modalities [J].
De Robertis, Riccardo ;
D'Onofrio, Mirko ;
Demozzi, Emanuele ;
Crosara, Stefano ;
Canestrini, Stefano ;
Mucelli, Roberto Pozzi .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (23) :7231-7241